BATS BZX Real-Time Price
As of 12:46pm ET
| -11.37 / -13.95%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 111.00, with a high estimate of 145.00 and a low estimate of 90.00. The median estimate represents a +58.21% increase from the last price of 70.16.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.